These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Bidirectional modulation of classical fear conditioning in mice by 5-HT(1A) receptor ligands with contrasting intrinsic activities. Youn J, Misane I, Eriksson TM, Millan MJ, Ogren SO, Verhage M, Stiedl O. Neuropharmacology; 2009; 57(5-6):567-76. PubMed ID: 19607850 [Abstract] [Full Text] [Related]
26. Desensitization of pre and post synaptic 5-HT-1A receptor responses following long term consumption of sugar rich diet: implications for sugar-induced obesity. Jabeen B, Haleem DJ. Pak J Pharm Sci; 2008 Oct; 21(4):327-32. PubMed ID: 18930850 [Abstract] [Full Text] [Related]
27. Anticataleptic 8-OH-DPAT preferentially counteracts with haloperidol-induced Fos expression in the dorsolateral striatum and the core region of the nucleus accumbens. Ohno Y, Shimizu S, Imaki J, Ishihara S, Sofue N, Sasa M, Kawai Y. Neuropharmacology; 2008 Oct; 55(5):717-23. PubMed ID: 18585397 [Abstract] [Full Text] [Related]
28. Recovery of locomotor function with combinatory drug treatments designed to synergistically activate specific neuronal networks. Guertin PA. Curr Med Chem; 2009 Oct; 16(11):1366-71. PubMed ID: 19355892 [Abstract] [Full Text] [Related]
29. Interplay between glutamate and serotonin within the dorsal periaqueductal gray modulates anxiety-related behavior of rats exposed to the elevated plus-maze. Moraes CL, Bertoglio LJ, Carobrez AP. Behav Brain Res; 2008 Dec 12; 194(2):181-6. PubMed ID: 18675851 [Abstract] [Full Text] [Related]
30. The effects of 5-HT1A and 5-HT2C receptor agonists on behavioral satiety sequence in rats. López-Alonso VE, Mancilla-Díaz JM, Rito-Domingo M, González-Hernández B, Escartín-Pérez RE. Neurosci Lett; 2007 Apr 18; 416(3):285-8. PubMed ID: 17324511 [Abstract] [Full Text] [Related]
31. Specific role of dopamine D1 receptors in spinal network activation and rhythmic movement induction in vertebrates. Lapointe NP, Rouleau P, Ung RV, Guertin PA. J Physiol; 2009 Apr 01; 587(Pt 7):1499-511. PubMed ID: 19204052 [Abstract] [Full Text] [Related]
32. Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology. Cussac D, Palmier C, Finana F, De Vries L, Tardif S, Léger C, Bernois S, Heusler P. J Pharmacol Exp Ther; 2009 Oct 01; 331(1):222-33. PubMed ID: 19605522 [Abstract] [Full Text] [Related]
33. Anxiogenesis in adult rats treated chronically with cocaine during adolescence: effects of extended abstinence and 8-OH-DPAT treatment. Santucci AC, Madeira E. Brain Res Bull; 2008 Jul 01; 76(4):402-11. PubMed ID: 18502317 [Abstract] [Full Text] [Related]
34. Oral administration of a tri-therapy for central pattern generator activation in paraplegic mice: proof-of-concept of efficacy. Guertin PA, Ung RV, Rouleau P. Biotechnol J; 2010 Apr 01; 5(4):421-6. PubMed ID: 20349462 [Abstract] [Full Text] [Related]
35. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum. Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D. Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244 [Abstract] [Full Text] [Related]
36. Combination therapy improves walking in spinal cord transaction. Chi JH. Neurosurgery; 2009 Dec 12; 65(6):N10-1. PubMed ID: 19934949 [No Abstract] [Full Text] [Related]
37. Modulation of locomotor activity by multiple 5-HT and dopaminergic receptor subtypes in the neonatal mouse spinal cord. Madriaga MA, McPhee LC, Chersa T, Christie KJ, Whelan PJ. J Neurophysiol; 2004 Sep 12; 92(3):1566-76. PubMed ID: 15163678 [Abstract] [Full Text] [Related]
38. Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies. Barrondo S, Sallés J. Neuropharmacology; 2009 Feb 12; 56(2):455-62. PubMed ID: 18951909 [Abstract] [Full Text] [Related]
39. WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D(4) receptor activation. Marona-Lewicka D, Nichols DE. Behav Pharmacol; 2009 Feb 12; 20(1):114-8. PubMed ID: 19179855 [Abstract] [Full Text] [Related]
40. Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist. Deseure K, Bréand S, Colpaert FC. Eur J Pharmacol; 2007 Jul 30; 568(1-3):134-41. PubMed ID: 17512927 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]